283 related articles for article (PubMed ID: 3310868)
1. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Utsui Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
[TBL] [Abstract][Full Text] [Related]
5. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
Okamoto S; Hamana Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1111-6. PubMed ID: 3499115
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
[TBL] [Abstract][Full Text] [Related]
9. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
Yokota T; Suzuki E; Arai K
Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefodizime.
Knothe H; Shah PM
Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
Angehrn P; Hohl P; Then RL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
Wise R; Andrews JM; Ashby JP; Thornber D
J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
Wise R; Cross C; Andrews JM
Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
[TBL] [Abstract][Full Text] [Related]
17. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]